Joseph A. Rafferty

1.8k total citations
47 papers, 1.5k citations indexed

About

Joseph A. Rafferty is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Joseph A. Rafferty has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 15 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Joseph A. Rafferty's work include DNA Repair Mechanisms (26 papers), Carcinogens and Genotoxicity Assessment (12 papers) and Folate and B Vitamins Research (8 papers). Joseph A. Rafferty is often cited by papers focused on DNA Repair Mechanisms (26 papers), Carcinogens and Genotoxicity Assessment (12 papers) and Folate and B Vitamins Research (8 papers). Joseph A. Rafferty collaborates with scholars based in United Kingdom, United States and Spain. Joseph A. Rafferty's co-authors include Geoffrey P. Margison, Amanda J. Watson, Rhoderick H. Elder, GP Margison, LJ Fairbairn, E.S. Newlands, J Baer, Andrea Freeman, Leslie J. Fairbairn and Philip M. Potter and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Joseph A. Rafferty

47 papers receiving 1.5k citations

Peers

Joseph A. Rafferty
J Frei Canada
Vitaly A. Polunovsky United States
Rita Humeniuk United States
Lydia Santell United States
Igor B. Rosenwald United States
Joseph A. Rafferty
Citations per year, relative to Joseph A. Rafferty Joseph A. Rafferty (= 1×) peers Xincheng Lu

Countries citing papers authored by Joseph A. Rafferty

Since Specialization
Citations

This map shows the geographic impact of Joseph A. Rafferty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Rafferty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Rafferty more than expected).

Fields of papers citing papers by Joseph A. Rafferty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. Rafferty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Rafferty. The network helps show where Joseph A. Rafferty may publish in the future.

Co-authorship network of co-authors of Joseph A. Rafferty

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Rafferty. A scholar is included among the top collaborators of Joseph A. Rafferty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Rafferty. Joseph A. Rafferty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saeed, Hesham, et al.. (2002). Evidence for the presence of active cytochrome P450 systems in Schistosoma mansoni and Schistosoma haematobium adult worms. FEBS Letters. 519(1-3). 205–209. 27 indexed citations
2.
Thompson, Michael J., et al.. (2000). Role of O6-alkylguanine-DNA alkyltransferase in the resistance of mouse spermatogenic cells to O6-alkylating agents. Reproduction. 119(2). 339–346. 3 indexed citations
3.
Bibby, M.C., Michael J. Thompson, Joseph A. Rafferty, Geoffrey P. Margison, & R. Stanley McElhinney. (1999). Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice. British Journal of Cancer. 79(9-10). 1332–1339. 7 indexed citations
5.
Deans, Bryan, Rhoderick H. Elder, Joseph A. Rafferty, et al.. (1999). Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines. British Journal of Cancer. 80(7). 940–945. 27 indexed citations
7.
Fairbairn, LJ, et al.. (1998). Modulation of O6-alkylating agent induced clastogenicity by enhanced DNA repair capacity of bone marrow cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 416(1-2). 1–10. 14 indexed citations
8.
Chinnasamy, Nachimuthu, Joseph A. Rafferty, Geoffrey P. Margison, Peter O’Connor, & Rhoderick H. Elder. (1997). Induction of O 6 -Alkylguanine-DNA-Alkyltransferase in the Hepatocytes of Rats Following Treatment with 2-Acetylaminofluorene. DNA and Cell Biology. 16(4). 493–500. 8 indexed citations
9.
Rafferty, Joseph A., Ian Hickson, L. S. Lashford, et al.. (1996). Chemoprotection of normal tissues by transfer of drug resistance genes. Cancer and Metastasis Reviews. 15(3). 365–383. 29 indexed citations
10.
Abril, Nieves, et al.. (1994). Effect of ogt expression on mutation induction by methyl-, ethyl- and propylmethanesulphonate in Escherichia coli K12 strains. Molecular and General Genetics MGG. 242(6). 744–748. 15 indexed citations
11.
Fairbairn, Leslie J., et al.. (1994). bcl‐2 delay of alkylating agent‐induced apoptotic death in a murine hemopoietic stem cell line. Molecular Carcinogenesis. 11(1). 49–55. 17 indexed citations
12.
Frayling, Ian M., et al.. (1994). Evidence for the simultaneous expression of alternatively spliced alkylpurine N-glycosylase transcripts in human tissues and cells. Carcinogenesis. 15(12). 2957–2960. 22 indexed citations
13.
Baer, J, Andrea Freeman, E.S. Newlands, et al.. (1993). Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. British Journal of Cancer. 67(6). 1299–1302. 171 indexed citations
14.
Lee, Siow Ming, Joseph A. Rafferty, Michael Bromley, et al.. (1992). Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma. British Journal of Cancer. 66(2). 355–360. 45 indexed citations
15.
Lee, Siow Ming, D. Crowther, J.H. Scarffe, et al.. (1992). Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation. British Journal of Cancer. 66(2). 331–336. 15 indexed citations
16.
Rafferty, Joseph A., Chun‐Yang Fan, Philip M. Potter, et al.. (1992). Tissue‐specific expression and induction of human O6‐alkylguanine‐dna alkyltransferase in transgenic mice. Molecular Carcinogenesis. 6(1). 26–31. 5 indexed citations
18.
Rafferty, Joseph A., Rhoderick H. Elder, Amanda J. Watson, et al.. (1992). Isolation and partial characterisation of a Chinese hamster O6-alkylguanine-DNA alky It ransferase cDNA. Nucleic Acids Research. 20(8). 1891–1895. 17 indexed citations
19.
Santibanez‐Koref, Mauro, Rhoderick H. Elder, Chun‐Yang Fan, et al.. (1992). Isolation and partial characterization of murine O6‐alkyiguanine‐DNA‐alkyltransferase: Comparative sequence and structural properties. Molecular Carcinogenesis. 5(2). 161–169. 18 indexed citations
20.
Potter, Philip M., Joseph A. Rafferty, Lynn Cawkwell, et al.. (1991). Isolation and cDNA cloning of a rat; O6-alkyllguanine-DNA-alkyltransferase gene, molecelar analysis of expression in rat liver. Carcinogenesis. 12(4). 727–733. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026